Showing results (171-180 of 207) with videos related to

Sort By:
Pageof 21
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|June 1, 1996
Preoperative radiotherapy in stage I/II endometrial adenocarcinomaP Maingon, J C Horiot, J Fraisse, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|September 10, 2017
[Dose constraints to organs at risk for conformational and stereotactic radiotherapy: Small bowel and duodenum]F Goupy, E Chajon, J Castelli, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 12, 2013
DCF (docetaxel, cisplatin and 5-fluorouracil) chemotherapy is a promising treatment for recurrent advanced squamous cell anal carcinomaS Kim, M Jary, L Mansi, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|December 31, 2016
Implementation of intensity-modulated radiotherapy for head and neck cancers in routine practiceC Bednarek, T V F Nguyen, M Puyraveau, et al.
European Journal of Cancer Care|May 8, 2013
Impact of neoadjuvant chemotherapy on survival in breast cancer patients in daily practice: a population-based studyT S Dabakuyo, A Arnaud, P Maingon, et al.
European Journal of Cancer (Oxford, England : 1990)|March 6, 2012
Development of clinical trial protocols involving advanced radiation therapy techniques: the European Organisation for Research and Treatment of Cancer Radiation Oncology Group approachA Fairchild, R Bar-Deroma, L Collette, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|May 8, 2018
[Advances in the management of cervical lymphadenopathies of unknown primary with intensity modulated radiotherapy: Doses and target volumes]I Troussier, G Klausner, E Blais, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|June 13, 2001
[Multicenter study on dose escalation with conformal and conventional radiotherapy for the treatment of localized prostatic cancer. Preliminary results of tolerance and quality of life]V Beckendorf, P Pommier, C Carrie, et al.
European Journal of Cancer (Oxford, England : 1990)|April 20, 2012
Neoadjuvant therapy for breast cancer has no benefits on overall survival or on the mastectomy rate in routine clinical practice. A population-based study with a median follow-up of 11 years using propensity score matchingI Le Ray, S Dabakuyo, G Crehange, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|July 25, 2015
[Interobserver variability study for daily cone beam computed tomography registration of prostate volumetric modulated arc therapy]N Zahra, C Monnet, E Bartha, et al.
Pageof 21